Insilico Medicine's ISM8969 Achieves IND Approval from FDA, Pioneering AI-Led Drug Development Insilico Medicine's ISM8969 secures IND approval from the FDA, paving the way for clinical trials, showcasing AI's potential in drug development.

Insilico Medicine's ISM8969 Achieves IND Approval from FDA, Pioneering AI-Led Drug Development #United_States #Cambridge #Insilico_Medicine #NLRP3_Inhibitor #ISM8969